Company Filing History:
Years Active: 2022
Title: The Innovations of Daniel Garry
Introduction
Daniel Garry is an accomplished inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the development of bacterial delivery vehicles. His innovative work focuses on enhancing the detection and quantification of these vehicles in various applications.
Latest Patents
Daniel Garry holds a patent for "Bacterial delivery vehicles comprising tracer nucleic acid sequences." This patent relates to genetically tagged bacterial delivery vehicles that include unique tracer nucleic acid sequences, referred to as 'tracers.' These tracers are designed for detecting and quantifying the presence of multiple bacterial delivery vehicles within a mixture. The methods outlined in the patent utilize amplification techniques with primers that bind to the unique tracer sequences. This technology has potential applications in quality control for pharmaceutical compositions.
Career Highlights
Throughout his career, Daniel has demonstrated a commitment to advancing biotechnological innovations. His work at Eligo Bioscience has positioned him as a key player in the field. He has focused on developing solutions that improve the efficacy and safety of bacterial delivery systems.
Collaborations
Daniel collaborates with Igor Stzepourginski, a fellow innovator in the field. Together, they work on projects that aim to push the boundaries of current biotechnological applications.
Conclusion
Daniel Garry's contributions to the field of biotechnology, particularly through his patented innovations, highlight his role as a leading inventor. His work continues to influence advancements in the detection and application of bacterial delivery vehicles.